(lp0
S'Clovis Oncology spikes; receives early FDA approval for advanced cancer drug CNBC - Dec 19, 2016 Shares of Clovis Oncology closed up 8.82 percent Monday as the company received early approval for its advanced ovarian cancer drug Rubraca .Avella selected by Clovis Oncology, Inc. to distribute RUBRACA  - PR Newswire '
p1
aS"Why Clovis Oncology Inc. Is Soaring Today Motley Fool - Sep 8, 2016 Clovis Oncology disclosed in a SEC filing today that the FDA is not planning an advisory committee meeting to discuss the company's New Drug Application, or NDA, for rucaparib.Clovis Oncology Up As FDA Skips Review Panel For New Drug - Investor's Business DailyClovis Oncology  Reports FDA Doesn't Plan to Hold Advisory Committee ... - StreetInsider.com"
p2
aS"Why Clovis Oncology Inc. Rose 52.7% in September Motley Fool - Oct 10, 2016 It is also worth remembering that Clovis does not exactly have a perfect history with the FDA. In addition, investors need to remember that Clovis will have to make a series of milestone payments to Pfizer if rucaparib does win FDA approval. Granted ...Clovis Oncology Inc ' Me-Too Ovarian Cancer Drug Can't Match Rival - Scibility Media"
p3
aS'Clovis Oncology 4Q Loss Misses Street  Investopedia - Feb 23, 2017 Clovis Oncology recorded an increase in general and administrative expenses, which came in at $12.2 million for the fourth quarter primarily attributed to commercialization of Rubraca.JP Morgan Boosts Price Target for Clovis Oncology Inc  on Back of ... - Smarter AnalystClovis Oncology, Inc.  Gets news from FDA, Merrill Lynch - StockNewsUnion'
p4
aS'Guggenheim Capital LLC Purchases Shares of 63568 Clovis Oncology Inc  The Cerbat Gem - 4 hours ago Clovis Oncology logo Guggenheim Capital LLC acquired a new stake in Clovis Oncology Inc  during the fourth quarter, according to its most recent Form 13F filing with the SEC.Sales Growth Analysis: Clovis Oncology, Inc. , Under Armour, Inc.  - USA Commerce DailyAre Technical Indicators Looking Better For YRC Worldwide Inc. , Clovis ... - Post Analyst'
p5
aS"Today's Research Reports on Biotech Stocks to Watch: Nektar Therapeutics and ... Yahoo Finance - Apr 10, 2017 NEW YORK, NY / ACCESSWIRE / April 10, 2017 / The iShares NASDAQ Biotechnology Index ETF gained 0.80 percent to close at 290.52, up 9.47 percent year-to-date."
p6
aS'Clovis Oncology Announces Data Presentations at AACR Annual Meeting 2017 Yahoo Finance - Mar 28, 2017 Clovis Oncology, Inc.  today announced that rucaparib preclinical data will be presented at the American Association for Cancer Research  Annual Meeting 2017.Clovis Looks Vastly Overpriced - Seeking AlphaClovis Oncology Inc.  Moves Lower on Volume Spike for March 27 - Equities.com'
p7
aS'Clovis Oncology Stock-Drop Claims Still Fall Short, Court Told Law360  - Mar 20, 2017 Law360, New York  -- Three underwriters accused of helping Clovis Oncology Inc. defraud investors in a stock offering asked a Colorado federal court Friday to dismiss claims against them, saying changes that were supposed&nbsp;...'
p8
aS'Market Focus: Zooming in on Shares of Clovis Oncology, Inc.  Baldwin Journal - 5 hours ago Clovis Oncology, Inc.  has a current EV or Enterprise Value of 2639580. The EV displays how the market assigns value to a firm as a whole.'
p9
aS'Clovis Oncology Inc.  Moves Lower on Volume Spike for April 07 Equities.com - Apr 7, 2017 Clovis Oncology Inc.  traded on unusually high volume on Apr. 07, as the stock lost 2.41% to close at $55.46. On the day, Clovis Oncology Inc. saw 3.18 million shares trade hands on 23,162 trades. Considering that the stock averages only a daily&nbsp;...Hot Stock Update: Clovis Oncology, Inc.  - HugoPressSales Growth Analysis: Tenaris SA , Clovis Oncology, Inc.  - USA Commerce Daily'
p10
a.